D'ASCENZIO, MELISSA
 Distribuzione geografica
Continente #
NA - Nord America 779
EU - Europa 207
AS - Asia 109
AF - Africa 6
SA - Sud America 3
Totale 1.104
Nazione #
US - Stati Uniti d'America 776
IT - Italia 92
SG - Singapore 41
IN - India 37
DE - Germania 32
CN - Cina 24
SE - Svezia 21
GB - Regno Unito 20
FI - Finlandia 18
UA - Ucraina 7
RU - Federazione Russa 4
TG - Togo 4
AR - Argentina 3
CA - Canada 3
TR - Turchia 3
ES - Italia 2
FR - Francia 2
IE - Irlanda 2
MA - Marocco 2
MY - Malesia 2
RO - Romania 2
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
EE - Estonia 1
ID - Indonesia 1
LV - Lettonia 1
NO - Norvegia 1
Totale 1.104
Città #
Fairfield 144
Woodbridge 80
Ashburn 72
Seattle 60
Cambridge 51
Wilmington 50
Houston 46
Rome 33
Singapore 31
Santa Clara 26
Chandler 21
Ann Arbor 17
Dearborn 17
Princeton 17
New York 16
Plano 15
San Paolo di Civitate 14
Latina Scalo 12
Lawrence 12
Beijing 11
San Diego 11
Grafing 9
Millbury 9
Boston 7
Cagliari 6
Helsinki 5
Norwalk 5
Lomé 4
Andover 3
Bremen 3
Falkenstein 3
Federal 3
Hefei 3
Jacksonville 3
Bursa 2
Chieti 2
Delhi 2
Des Moines 2
Dimāpur 2
Dublin 2
Falls Church 2
Fasano 2
Fonte Nuova 2
Laurel 2
Meknes 2
Redwood City 2
Salamanca 2
Simi Valley 2
Aizawl 1
Berlin 1
Bolzano Vicentino 1
Campobello Di Mazara 1
Changchun 1
Dhaka 1
Fulham 1
Fuzhou 1
Guangzhou 1
Huzhou 1
Indiana 1
Istanbul 1
Jakarta 1
Janesville 1
Kuching 1
Kunming 1
Las Vegas 1
Los Angeles 1
Mannheim 1
Massimeno 1
Montréal 1
Moscow 1
Munich 1
Oslo 1
Ottawa 1
Pontinia 1
Provo 1
Riga 1
Shanghai 1
Shenyang 1
Sofia 1
Southend 1
Tallinn 1
Taramani 1
Tirana 1
Toronto 1
Washington 1
Wuhan 1
Totale 885
Nome #
Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity 114
Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma 100
Recent advances in the development of selective human MAO-B inhibitors: (Hetero)arylidene-(4-substituted-thiazol-2- yl)hydrazines 95
Synthesis and selective inhibition of human monoamine oxidases of a large scaffold of (4,5-substituted-thiazol-2-yl)hydrazones 86
4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis 86
Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii 82
Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitors 76
Cyclic tertiary sulfamates: Selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives 75
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII—A new scaffold for designing isoform-selective inhibitors 72
Synthesis, anti-Candida activity, and cytotoxicity of new (4-(4-iodophenyl)thiazol-2-yl)hydrazine derivatives 66
Selective MAO-B inhibitors: a lesson from natural products 62
Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential 60
null 54
null 50
Synthesis and biological evaluation of new potential co-adjuvants for the treatment of Parkinson’s disease and a new catalytic, asymmetric approach to the synthesis of fused heterocycles of biological interest. 42
New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: Biological evaluation and molecular modelling studies 19
Opening new scenarios for human MAO inhibitors 15
Totale 1.154
Categoria #
all - tutte 2.972
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.972


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020228 0 0 0 0 0 39 49 40 47 28 15 10
2020/2021101 8 11 9 3 0 10 0 9 26 18 6 1
2021/2022173 1 13 20 2 19 5 9 14 11 11 38 30
2022/2023136 33 32 1 11 11 12 2 8 15 1 10 0
2023/2024104 5 13 5 6 8 35 0 15 1 6 1 9
2024/202585 1 11 16 12 21 24 0 0 0 0 0 0
Totale 1.154